Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
The Department of Pathology and Cell Biology at Columbia University Irving Medical Center seeks a highly qualified researcher with knowledge in molecular oncology and cytoskeletal remodeling using
-
This position involves direct participation in research aimed at understanding the molecular mechanisms of neurodegenerative and neurodevelopmental diseases caused by dysregulation of RNA metabolism. The projects employ multidisciplinary approaches in the areas of genomics, RNA/protein...
-
• Bioengineering • Systems Biology • Orally Related Diseases Reporting to the Section Chair, successful candidates are expected to develop, sustain and lead an active, highly visible, externally funded
-
most vibrant and culturally rich cities. In the laboratory of Dr. Richard Axel the incumbent will use genetics, molecular biology, and biochemistry to characterize molecular mechanisms of growth and
-
and experience related to cell and developmental biology, lung diseases, and other pulmonary-related diseases. Our research programs study acute lung injury, asthma, cystic fibrosis, lung
-
biology, statistical genetics, and molecular biology. We are looking to add another biostatistician to our team. Thematically, we pursue projects related to Alzheimer's disease, Multiple Sclerosis
-
the molecular and cellular mechanisms involved in the pathogenesis of pancreatic cancer, as well as intestinal biology. This scientist is expected to complete a major manuscript in preparation that defines
-
/) brings together over 40 basic and clinical research groups working on different aspects of motor neuron biology and disease. One of the strengths of the MNC is a membership housed in multiple departments
-
on advancing biomedical research through the study of molecular genetics, chemical biology, and structural biology to identify specific and novel targets to modify the function of living systems and impact
-
intersection of oncology, tumor immunology, genomics, radiation biology, systems biology. The successful candidate will be integral to investigator-initiated and early phase clinical trials for clinical